RespireRx Pharmaceuticals Inc (fka RSPI)

[Aiming4]

Neuro provided a completely rational explanation for just about every argument you tossed against the wall about the AD trial.

Everyone following this msg board has read that reply chain and has reached their own conclusions about whether the accusations you made against the company were accurate or not.

You want to ignore the one salient point about the options mgmt received... it's an industry norm. No I didn't like them... no IMO they didn't deserve them. But read it again: it's an industry norm.

I don't find it productive to go off fighting windmills like the option grants, I'd rather figure out whether COR still has any investment potential or not.

And the key question from my previous post remains:

If you have any damning concrete information about mgmt that you'd like to share, we'd all love to hear it.